Cibc Private Wealth Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 7,664 shares of XERS stock, worth $25,597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,664
Previous 5,664
35.31%
Holding current value
$25,597
Previous $12,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
134Shares Held
56.4MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$25.6 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.1 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$16.1 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$10.9 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $454M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...